Home/Filings/4/0000950170-25-057620
4//SEC Filing

Robb Gary Charles 4

Accession 0000950170-25-057620

CIK 0001088856other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 7:41 PM ET

Size

7.8 KB

Accession

0000950170-25-057620

Insider Transaction Report

Form 4
Period: 2025-01-27
Robb Gary Charles
Chief Financial Officer
Transactions
  • Gift

    Common Stock

    2025-01-27+31311,211 total(indirect: By Children)
  • Gift

    Common Stock

    2025-01-27+31311,211 total(indirect: By Children)
Holdings
  • Common Stock

    18,865
Footnotes (2)
  • [F1]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
  • [F2]Includes 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Documents

1 file

Issuer

CORCEPT THERAPEUTICS INC

CIK 0001088856

Entity typeother

Related Parties

1
  • filerCIK 0001529655

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 7:41 PM ET
Size
7.8 KB